Article

Dr. Kolodziej Discusses Personalized Medicine in Oncology

Michael Kolodziej, MD, National Medical Director for Oncology Strategies, Aetna, says that the rapid emergence of precision medicine was one of the more interesting topics discussed at the ASCO 2013 Annual Meeting.

Michael Kolodziej, MD, National Medical Director for Oncology Strategies, Aetna, says that the rapid emergence of precision medicine was one of the more interesting topics discussed at the ASCO 2013 Annual Meeting. Dr Kolodziej discussed the importance of understanding how the information on specific genetic mutations to tailor therapy that is optimal for each patient will be used. "I think the discussion about how to develop the necessary quantum of information that you need to prove that it actually works," said Dr Kolodziej "Because from a payer perspective clinical utility is going to be the most important thing."

This video was taken on June 1, 2013, at the ASCO Annual Meeting 2013 in Chicago, IL.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Dr Carrie Kitko
Dr Ibrahim Aldoss
Dr Pankit Vachhani
Dr Ibrahim Aldoss
Dr Pankit Vachhani
Dr John Mascarenhas
CK Wang, MD, COTA
Dr Pankit Vachhani
Dr John Mascarenhas
Dr John Mascarenhas
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo